Brain Malformation Panel
Summary and Pricing
Test Method
Exome Sequencing with CNV DetectionTest Code | Test Copy Genes | Panel CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
12613 | Genes x (52) | 81479 | 81403(x1), 81404(x3), 81405(x4), 81406(x4), 81407(x1), 81479(x91) | $990 | Order Options and Pricing |
Pricing Comments
We are happy to accommodate requests for testing single genes in this panel or a subset of these genes. The price will remain the list price. If desired, free reflex testing to remaining genes on panel is available. Alternatively, a single gene or subset of genes can also be ordered via our Custom Panel tool.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).
Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).
Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Brain malformation is a group of complex conditions influenced by both genetic and environmental factors such as chemicals, infections or radiation during pregnancy. This brain malformation panel focuses on important brain malformations including tubulinopathies, cortical dysplasia, cortical malformations, periventricular heterotopia, lissencephaly, polymicrogyria, pontocerebellar hypoplasia, and muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies. Most brain malformations have onset before birth. The symptoms vary with different causes. For example, in tubulinopathies, the major features include lissencephaly, pachygyria, cortical dysplasia, simplified gyral pattern, microlissencephaly, abnormality of corpus callosum, brain stem and cerebellum. These malformations led to severe intellectual disability and early onset seizures or infantile spasms (Brock et al. 2018. PubMed ID: 29706637; Poirier et al. 2013. PubMed ID: 23603762; Di Donato et al. 2018. PubMed ID: 29671837; Romaniello et al. 2017. PubMed ID: 28677066).
For diagnosis of brain malformation, brain imaging techniques such as CT and MRI are the most powerful tools. For example, in the case of tubulinopathies, MRI shows pachygyric cortex with posterior to anterior gradient, enlarged lateral ventricles, variable degrees of reduced white matter volume (Brock et al. 2018. PubMed ID: 29706637; Poirier et al. 2013. PubMed ID: 23603762; Romaniello et al. 2017. PubMed ID: 28677066). In defects of neuronal migration, MRI reveals diffuse periventricular heterotopia, thin corpus callosum, and cortical and hippocampal atrophy (Sheen et al. 2004. PubMed ID: 14647276; Tanyalçin et al. 2013. PubMed ID: 23755938).
Genetics
The genetic etiology of the brain malformation is extremely heterogeneous, ranging from monogenic causes with little or no influence from modifiers or environmental factors to genetically complex forms. In this panel, we mainly focus on a group of genes causative for certain congenital brain malformations. These selected genes have been well documented, such as cortical dysplasia due to defects in structural protein tubulin (TUBA1A, TUBB2A, TUBB2B, TUBB3, TUBB, TUBG1,TUBA8), cortical dysplasia due to defects in actin regulation and neuronal migration (CTNNA2), cortical dysplasia due to defects in microtubule proteins (KIF2A, KIF5C, DYNC1H1), Baraitser-Winter syndrome or lissencephaly due to defect in actin cytoskeleton and microtubule associated proteins (ACTB, ACTG1, DCX), lissencephaly or cerebellar hypoplasia due to defect in Reelin signaling (RELN, VLDLR), cortical malformations or lissencephaly due to defect in epithelial structures laminin or extracellular matrix laminin (LAMC3, LAMB1), heterotopia due to defect in neuronal migration and neurogenesis (ARFGEF2, FLNA, NEDD4L), and heterotopia and lissencephaly due to defects in platelet-activating factor acetylhydrolase (PAFAH1B1). This panel also include genes involving other various cellular functions which cause lissencephaly (ARX, KATNB, MACF1, NDE1, TMTC3), muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies (FKRP, FKTN, LARGE1, POMGNT1, POMT1, POMT2). In total, this panel covers more than 50 disorders (Bahi-Buisson and Cavallin et al. 2016. PubMed ID: 27010057; Spalice et al. 2009. PubMed ID: 19120042; Lange et al. 2015. PubMed ID: 26471271; Parrini et al. 2006. PubMed ID: 16684786; Barak et al. 2011. PubMed ID: 21572413; Bouchet et al. 2007. PubMed ID: 17559086; Di Donato et al. 2018. PubMed ID: 29671837). Brain malformation can be inherited in autosomal dominant, autosomal recessive and X-linked manner. The type of pathogenic variant varies with different genes. For example, the vast majority of pathogenic variants in genes involving tubulinopathies occurr de novo (Bahi-Buisson and Cavallin. 2016. PubMed ID: 27010057; Rodan et al. 2017. PubMed ID: 27770045). Germline mosaicism has been seen in a patient with tubulinopathy (Brock et al. 2018. PubMed ID: 29706637).
See individual gene summaries for more information about molecular biology of gene products and spectra of pathogenic variants.
Clinical Sensitivity - Sequencing with CNV PGxome
Brain malformations are clinically and genetically heterogeneous. The sensitivity is variable depending on different disorders. For example, in analysis of FLNA in 120 patients with classical bilateral periventricular nodular heterotopia and periventricular heterotopia, 25 pathogenic variants were detected in 40 patients (Parrini et al. 2006. PubMed ID: 16684786). In a study of the fetal form of type II lissencephaly, 22 out of 41 unrelated families had positive results in genes causative for muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies (Bouchet et al. 2007. PubMed ID: 17559086). When considering lissencephaly, the four most common genes (PAFAH1B1, DCX, TUBA1A, and DYNC1H1) account for 69% of cases (Di Donato et al. 2018. PubMed ID: 29671837).
Testing Strategy
This test is performed using Next-Gen sequencing with additional Sanger sequencing as necessary.
This panel typically provides 97.5% coverage of all coding exons of the genes plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define coverage as ≥20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).
Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).
Indications for Test
The brain malformation panel is recommended for patients suspected to have tubulinopathies, cortical dysplasia, cortical malformations, periventricular heterotopia, lissencephaly, polymicrogyria, pontocerebellar hypoplasia, and muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies.
The brain malformation panel is recommended for patients suspected to have tubulinopathies, cortical dysplasia, cortical malformations, periventricular heterotopia, lissencephaly, polymicrogyria, pontocerebellar hypoplasia, and muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies.
Genes
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Diseases
Related Test
Name |
---|
PGxome® |
Citations
- Bahi-Buisson and Cavallin. 2016. PubMed ID: 27010057
- Barak et al. 2011. PubMed ID: 21572413
- Bouchet et al. 2007. PubMed ID: 17559086
- Brock et al. 2018. PubMed ID: 29706637
- Di Donato et al. 2018. PubMed ID: 29671837
- Lange et al. 2015. PubMed ID: 26471271
- Parrini et al. 2006. PubMed ID: 16684786
- Poirier et al. 2013. PubMed ID: 23603762
- Rodan et al. 2017. PubMed ID: 27770045
- Romaniello et al. 2017. PubMed ID: 28677066
- Sheen et al. 2004. PubMed ID: 14647276
- Spalice et al. 2009. PubMed ID: 19120042
- Tanyalin et al. 2013. PubMed ID: 23755938
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
PGxome (Exome) Sequencing Panel
PGnome (Genome) Sequencing Panel
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.